Levodopa: History and Therapeutic Applications. - Wikidata - awgldk - TriplyDB

Levodopa: History and Therapeutic Applications.

Levodopa: History and Therapeutic Applications.

http://www.wikidata.org/entity/Q41626111

about

Levodopa: History and Therapeutic Applications.

http://www.wikidata.org/entity/Q41626111

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Levodopa: History and Therapeutic Applications.

@en

type

label

Levodopa: History and Therapeutic Applications.

@en

prefLabel

Levodopa: History and Therapeutic Applications.

@en

P1433

Q41626111-CF2EAF33-667F-4483-B33F-18BB874BBFB4

P1476

Q41626111-CAD34FCF-F7BE-4951-B277-14ECF056BD9F

P2093

Q41626111-13434147-4961-42FA-962E-2972ECEAD155

Q41626111-1ECB311A-CAD0-4808-962F-5B1ED8EE6629

P2860

Q41626111-0094348B-C5DE-4E70-8515-9301FD0D700A

Q41626111-01428D2E-0A86-4572-A097-3EC27BB8CEC9

Q41626111-238B6795-72F6-4132-9424-1F3B2BF28FBB

Q41626111-299EA3D9-0D19-41F0-A520-262741374D50

Q41626111-2E68B90C-3738-4FBD-9F95-32D932AC55E2

Q41626111-41971900-2C91-4AC4-848A-8482F2B1FB4D

Q41626111-4C258673-486D-45A5-8254-CA959FD19B12

Q41626111-54EE0091-2670-4711-BE44-3EC9FF2B1BEE

Q41626111-5C6CACEF-74EC-48F9-B170-D735FAF8761E

Q41626111-6108992F-E4BD-4387-A41A-5EB9C0BF140B

P304

Q41626111-6A50F22F-6D0E-4D0C-9E8E-06D0BE6D7925

P31

Q41626111-49271305-B366-47AB-89F4-5ADDF066412E

P356

Q41626111-A2D2518B-EBA0-41E8-8233-FCA11EBEF976

P433

Q41626111-8A9E6F33-BF7D-4212-ADF9-CB861E057767

P478

Q41626111-56B843BD-BFC5-4483-A210-95FF0B19A54B

P577

Q41626111-AE0D092F-465F-40E3-9222-3A791ACFFD1C

P698

Q41626111-D60A8FA2-B30E-47C4-B766-FEA0B9373F6F

P921

Q41626111-A6EB78F1-3A83-4006-AF02-6C72BE81D642

P932

Q41626111-61F1D036-8160-4CFF-80DE-B9CCE8318890

P356

AIAN.AIAN_241_17

P1433

Annals of Indian Academy of Neurology

P1476

Levodopa: History and Therapeutic Applications.

@en

P2093

Bahiya Sulthana

http://www.w3.org/2001/XMLSchema#string

Sujith Ovallath

http://www.w3.org/2001/XMLSchema#string

P2860

The history of dopamine and levodopa in the treatment of Parkinson's disease

Chemical structure and sympathomimetic action of amines

Treatment of parkinsonism with levodopa.

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia.]

Serotonin release as a possible mechanism of reserpine action.

Phaeochromocytoma catechols in urine and tumour tissue.

Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-en

5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease.

The neurochemistry of Parkinson's disease: effect of L-dopa therapy.

P304

185-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/AIAN.AIAN_241_17

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28904446

http://www.w3.org/2001/XMLSchema#string

P921

P932

5586109

http://www.w3.org/2001/XMLSchema#string